Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
Twist Bioscience (TWST) Expected to Beat Earnings Estimates: Should You Buy?
06:04pm, Thursday, 29'th Apr 2021
Twist Bioscience (TWST) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is a Beat in the Cards for Twist (TWS) This Earnings Season?
02:17pm, Thursday, 29'th Apr 2021
Investors will focus on the top-line and bottom-line numbers when Twist (TWST) reports fiscal second-quarter 2021 results.
AcornMed Selects Twist Bioscience Technology to Power Next Generation Precision Medicine Tests
10:00pm, Wednesday, 07'th Apr 2021
SOUTH SAN FRANCISCO, Calif & BEIJING--(BUSINESS WIRE)--AcornMed Biotechnology Co., Ltd. (AcornMed), a precision medicine organization that specializes in the testing and analysis of solid and blood tu
Twist's COVID-19 test, which can detect variants, gets authorized
08:36am, Wednesday, 24'th Mar 2021
Shares of Twist Bioscience Corp. were down 1.6% in premarket trading on Wednesday after the company said its in-vitro diagnostic test that can detect SARS-CoV-2 RNA received emergency authorization in
Twist Bioscience Begins Shipping of Synthetic RNA Controls for B.1.351 and P.1 Variants
08:00am, Monday, 15'th Mar 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist began shipping its new synthetic RNA reference controls, including B.1.351 and P.1, that have emerged in South Africa and Brazil, respectively.
ARKG: Precautionary Measures, But Transformational Objectives Remain Intact
09:23am, Monday, 22'nd Feb 2021
Cathie Wood and her team have shown investors that they have the capability to turn double-digit growth dreams into reality.
Twist Bioscience and Berry Genomics to Offer New NGS Solution to Advance Research and Precision Medicine
05:00am, Monday, 22'nd Feb 2021
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #DNA--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its s
Twist Bioscience Collaborates With Australia Based Specialist Provider For Whole Exome Capture Assay
12:44pm, Thursday, 18'th Feb 2021
Twist Bioscience Corp (NASDAQ: TWST) and Victorian Clinical Genetic Services (VCGS) have developed a novel whole-exome capture assay, which utilizes Next Generation Sequencing to conduct analysis
Which Stocks Look Ready To Breakout (Video)
12:00pm, Wednesday, 17'th Feb 2021
These stocks look ripe for a 2021 breakout. Seeking Alpha Top Stocks makes it easy to find the strongest stocks in the market.
Twist Bioscience Corporation (TWST) CEO Emily Leproust on Q1 2021 Results - Earnings Call Transcript
05:56pm, Friday, 05'th Feb 2021
Twist Bioscience Corporation (TWST) CEO Emily Leproust on Q1 2021 Results - Earnings Call Transcript
Why Twist Bioscience Stock Is Tanking Today
11:33am, Friday, 05'th Feb 2021
An analyst downgraded the stock despite its better-than-expected quarterly results.
Recap: Twist Bioscience Q1 Earnings
05:06pm, Thursday, 04'th Feb 2021
Shares of Twist Bioscience (NASDAQ:TWST) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 28.00% over the past year to ($0.72), wh
Twist Bioscience (TWST) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
01:33pm, Thursday, 28'th Jan 2021
Twist Bioscience (TWST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The InvestorPlace Q&A: Genomics, Telehealth and the Future of Healthcare with the ANEW ETF
08:21am, Wednesday, 27'th Jan 2021
One aspect of the ANEW ETF is focused on the bleeding edge of medical advances. Here's what you need to know if you're considering investing.
A Deep Dive into ARK ETFs
12:03pm, Wednesday, 20'th Jan 2021
We highlight the best performing ETFs managed by Cathie Wood
